Pfizer has won European Commission expanded approval of its Abrysvo vaccine for respiratory syncytial virus, or RSV, for use in all adults. The New York drugmaker on Tuesday said the extended ...
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...
While most people who have been vaccinated — or had measles as children — are protected from the virus, there are some ...
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
Vaxcyte plunges 56% even though its VAX-24 pneumonia vaccine shows positive phase two results in infants. Read more here.
The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.
A new report, “Enhancing Adult Vaccine Uptake: Challenges in Shared Clinical Decision Making and Risk-Based Recommendations,” released by the Global Healthy Living Foundation (GHLF ...
For those with chronic obstructive pulmonary disease (COPD), it’s important to know which vaccines will help prevent ... with certain risk conditions All adults 50 years of age or older Adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results